Thomas Videbaek, Executive Vice President, Novozymes.
BAGSVAERD, DENMARK: Novozymes has signed a definitive agreement to acquire Natural Industries based in Houston, US, to strengthen its position in bioagriculture. The acquisition expands Novozymes’ position in key high-value markets for sustainable bioagriculture solutions.
The companies did not disclose financial terms of the agreement. Natural Industries has annual revenues of $5 million. “I am excited to have the people and technologies of Natural Industries join our growing bioagriculture business. Natural Industries expands Novozymes’ position in the important biocontrol segment and improves capabilities to grow our business in key US markets on high-value crops like fruits and vegetables,” said Thomas Videbaek, Executive Vice President, Novozymes.
The biological solutions complement the use of traditional chemicals and pesticides, which have a world market worth $150 billion. By contrast, the emerging bioagriculture market is estimated to be worth about $1 billion with an annual growth rate of 10-15 per cent.
The bioagriculture market is driven by farmers wanting to utilize potent biological solutions. “By applying the right cocktail of biological technologies you can add 4 to 5 per cent to crop yields. This makes it a cost-effective solution for farmers to safeguard high investments in seeds and agricultural chemicals. Also, due to increasing consumer awareness, regulations and environmental impact, there is growing interest in biological solutions,” explained Videbaek.
“Natural Industries has a wealth of knowledge in biocontrol. The company has a proven portfolio of products, new pipeline opportunities and good market coverage for high-value crops in key regions of the US. The acquisition is a good example of how we can grow and utilize our platform and leading position in this area as well as accelerate innovation,” said Videbaek.
© WOC News